Lundbeckfond Ventures, the Denmark-based Lundbeck Foundation's life sciences investment entity known as LFI Life Science Investments until November, led the consortium investing $16m in Nexstim.
Nexstim, a Finland-based medical device company, has raised €11.4m ($16m) for its non-invasive brain diagnostic and therapy technologies.
Lundbeckfond Ventures, the Denmark-based Lundbeck Foundation’s life sciences investment entity known as LFI Life Science Investments until November, led the consortium investing in Nexstim.
Finnish pension fund Ilmarinen Mutual Pension Insurance Company, state development agencies Sitra and Finnish Industry Investment and venture capital firms HealthCap and Life Sciences Partners were also part of the consortium.
Lundbeckfond Ventures is a new evergreen life…